Critical Path Institute (C-Path) is an independent, non-profit organization dedicated to bringing scientists from the FDA, industry and academia together to collaborate and improve the drug development and regulatory process for medical products. C-Path’s aim is to accelerate the pace and reduce the costs of medical product development through the creation of new data standards, measurement standards, and methods standards that aid in the scientific evaluation of the efficacy and safety of new therapies.

C-Path, through its Coalition Against Major Diseases (CAMD) will serve as a consultant to the TED Initiative in its collaborations with FDA and Industry Partners.